A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections

Overview of attention for article published in Journal of Translational Medicine, August 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 11 X users

facebook: 2 Facebook pages

Readers on

mendeley: 80 Mendeley

Summary X Facebook

So far, Altmetric has seen 17 X posts from 11 X users, with an upper bound of 22,225 followers.

RT @lai_dama: "...como dije al inicio de este mensaje, efectos antivirales y de inmunomodulación muy efectivos contra diversas infecciones…

04 Jan 2022

Reply Repost Favourite

"...como dije al inicio de este mensaje, efectos antivirales y de inmunomodulación muy efectivos contra diversas infecciones respiratorias (por ejemplo: https://t.co/wvqcXzYU1f, 👇(sigue)

04 Jan 2022

Reply Repost Favourite

RT @wheezemd: A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in…

06 Sep 2019

Reply Repost Favourite

RT @wheezemd: A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in…

06 Sep 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.